Biology Is Only Limited by Our Own Imagination Today
Building on advances in genomics, machine learning, engineering, and manufacturing, Alexis Bio’s patented platform unlocks the greatest manufacturer of all: Nature.
Alexis Bio is applying nature’s insights to code biological solutions starting with our body’s primary immune barrier – our skin… and that’s just the beginning.
Here’s What our Engineers, Scientists,
and Leaders are Delivering Today
realSKIN™ by Alexis Bio is the first live biotherapeutic skin transplant to complete a Phase I/2 Clinical Trial and the first to receive U.S. FDA Orphan Drug Designation. Partnering burn centers believe that realSKIN™ will become an important medical countermeasure for the treatment of severe burns.
realNERVE™ by Alexis Bio is under peer-review in a major medical journal reporting findings from a large preclinical series evaluating the safety and efficacy of a novel live biotherapeutic nerve transplant. There is an unmet need for large gap peripheral nerve damage and realNERVE™ offers a new solution to help restore a patient’s quality of life.
realTISSUE™ involves the transplantation of multiple structures that may include cells, bone grafts, blood vessels, valves
and connective tissue.
"If the misery of our poor be caused not by the laws of nature, but by our institutions, great is our sin."
- Charles Darwin